VIMGF Stock - Vimian Group AB (publ)
Unlock GoAI Insights for VIMGF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $374.80M | $331.73M | $281.31M | $173.35M | $137.75M |
| Gross Profit | $258.30M | $229.43M | $193.99M | $122.85M | $95.52M |
| Gross Margin | 68.9% | 69.2% | 69.0% | 70.9% | 69.3% |
| Operating Income | $49.20M | $41.27M | $39.36M | $21.60M | $74.80M |
| Net Income | $18.50M | $9.84M | $-7,198,000 | $6.59M | $52.79M |
| Net Margin | 4.9% | 3.0% | -2.6% | 3.8% | 38.3% |
| EPS | $0.04 | $0.02 | $-0.02 | $0.02 | $0.14 |
Vimian Group AB (publ) engages in the animal health business worldwide. It operates through Specialty Pharma, MedTech, Diagnostics, and Veterinary Services segments. The company offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals under the Nextmune brand name; and molecular and immunodiagnostic solutions that are used by laboratories for veterinary specific applications with a focus on livestock and companion animal health markets under the Indical Bioscience brand name. It also provides procurement and tech-driven operations, such as online marketing, and education and HR, as well as a community for veterinary clinics through a membership-based platform under the VetFamily brand name; and orthopedic implants for veterinarians and universities under the Movora brand name. The company was incorporated in 2020 and is headquartered in Stockholm, Sweden.
Visit WebsiteEarnings History & Surprises
VIMGFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 27, 2026 | — | — | — | — |
Q1 2026 | Feb 12, 2026 | — | — | — | — |
Q4 2025 | Oct 22, 2025 | $0.02 | $0.01 | -41.4% | ✗ MISS |
Q3 2025 | Jul 18, 2025 | $0.03 | $0.02 | -38.8% | ✗ MISS |
Q2 2025 | Apr 29, 2025 | $0.02 | $0.01 | -63.4% | ✗ MISS |
Q1 2025 | Feb 13, 2025 | $0.02 | $0.02 | -6.9% | ✗ MISS |
Q4 2024 | Oct 24, 2024 | $0.02 | $-0.00 | -117.5% | ✗ MISS |
Q3 2024 | Aug 15, 2024 | $0.02 | $0.01 | -57.2% | ✗ MISS |
Q2 2024 | May 2, 2024 | $0.03 | $0.01 | -72.5% | ✗ MISS |
Q1 2024 | Feb 15, 2024 | $0.01 | $-0.01 | -229.4% | ✗ MISS |
Q3 2023 | Sep 30, 2023 | $0.01 | $0.02 | +18.5% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.01 | $0.01 | -46.9% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $0.03 | $0.01 | -57.7% | ✗ MISS |
Q1 2023 | Mar 8, 2023 | $0.05 | $-0.04 | -180.0% | ✗ MISS |
Q4 2022 | Nov 16, 2022 | $0.03 | $0.01 | -66.7% | ✗ MISS |
Q3 2022 | Aug 24, 2022 | $0.03 | $0.04 | +33.3% | ✓ BEAT |
Q2 2022 | May 24, 2022 | $0.03 | $0.02 | -33.3% | ✗ MISS |
Q1 2022 | Mar 9, 2022 | $0.03 | $0.02 | -32.0% | ✗ MISS |
Q4 2021 | Nov 26, 2021 | $0.02 | $0.01 | -50.0% | ✗ MISS |
Q3 2021 | Aug 25, 2021 | — | $0.02 | — | — |
Latest News
Frequently Asked Questions about VIMGF
What is VIMGF's current stock price?
What is the analyst price target for VIMGF?
What sector is Vimian Group AB (publ) in?
What is VIMGF's market cap?
Does VIMGF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to VIMGF for comparison